Combination of phage display and molecular grafting generates highly specific tumor-targeting miniproteins

Frankenstein′s peptide: The grafting of the binding domain from miniprotein Min-23 into the sunflower trypsin inhibitor (SFTI-I) peptide scaffold (see scheme) preserved its in vitro and in vivo binding specificity and proteolytic stability. The combination of these peptides was shown to be tumor-spe...

Full description

Saved in:
Bibliographic Details
Main Authors: Zoller, Frederic (Author) , Markert, Annette (Author) , Zhao, Wenye (Author) , Weichert, Wilko (Author) , Askoxylakis, Vasileios (Author) , Altmann, Annette (Author) , Mier, Walter (Author) , Haberkorn, Uwe (Author)
Format: Article (Journal)
Language:English
Published: November 13, 2012
In: Angewandte Chemie. International edition
Year: 2012, Volume: 51, Issue: 52, Pages: 13136-13139
ISSN:1521-3773
DOI:10.1002/anie.201203857
Online Access:Verlag, Volltext: http://dx.doi.org/10.1002/anie.201203857
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/anie.201203857
Get full text
Author Notes:Frederic Zoller, Annette Markert, Philippe Barthe, Wenye Zhao, Wilko Weichert, Vasileios Askoxylakis, Annette Altmann, Walter Mier, and Uwe Haberkorn
Description
Summary:Frankenstein′s peptide: The grafting of the binding domain from miniprotein Min-23 into the sunflower trypsin inhibitor (SFTI-I) peptide scaffold (see scheme) preserved its in vitro and in vivo binding specificity and proteolytic stability. The combination of these peptides was shown to be tumor-specific with a good binding affinity for delta-like ligand 4 (Dll4) protein. The use of SFTI-I as a peptide scaffold is ideal for hit-to-lead development.
Item Description:Gesehen am 23.08.2018
Physical Description:Online Resource
ISSN:1521-3773
DOI:10.1002/anie.201203857